CNS pipeline · person
Harry Jordan, MBA
Associate Vice President, Strategic Accounts at Emalex Biosciences, overseeing payer engagement, reimbursement strategy and integrated solutions for rare disease therapies. He has over 25 years of pharmaceutical leadership, having directed market access initiatives at Amryt Pharmaceuticals, Adamas Pharmaceuticals, Evofem Biosciences and Harmony Biosciences. He holds a bachelor's degree from Lock Haven University and an MBA from Regis University.
- 1 company
Courtesy Emalex Biosciences
Current roles
- Emalex Biosciences Inc.Associate Vice President, Strategic Accounts · Executive
Appears with
People sharing a company with Harry.
- Brent Paul · Emalex Biosciences Inc.
- Christine H. Soulje · Emalex Biosciences Inc.
- Christopher Wilson · Emalex Biosciences Inc.
- David Kim · Emalex Biosciences Inc.
- David Knouft · Emalex Biosciences Inc.
- Doug Frandsen · Emalex Biosciences Inc.
- Eric Messner · Emalex Biosciences Inc.
- Frederick Munschauer · Emalex Biosciences Inc.
- Gail Hartigan · Emalex Biosciences Inc.
- George Karkanias · Emalex Biosciences Inc.
- Jay White · Emalex Biosciences Inc.
- Jeffrey S. Aronin · Emalex Biosciences Inc.
- John Flatt · Emalex Biosciences Inc.
- Jose (Jesse) Zapata · Emalex Biosciences Inc.
- Joy Schleyer · Emalex Biosciences Inc.
- Ken Borgerding · Emalex Biosciences Inc.
- Lydia Shenouda · Emalex Biosciences Inc.
- Meredith M. Miller · Emalex Biosciences Inc.
- Paul Reinfelds · Emalex Biosciences Inc.
- Sarah Atkinson · Emalex Biosciences Inc.
- Tim Rudolphi · Emalex Biosciences Inc.
- Tom Stothoff · Emalex Biosciences Inc.
- Tracy Durgin · Emalex Biosciences Inc.
- Trish Rice · Emalex Biosciences Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.